Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Burisch

Showing results (261-270 of 272) with videos related to

Pageof 28
Sort By:
Journal of Crohn'S & Colitis|November 20, 2019
ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical TreatmentMichel Adamina, Stefanos Bonovas, Tim Raine, et al.
Journal of Clinical Medicine|July 2, 2021
Effectiveness of Third-Class Biologic Treatment in Crohn's Disease: A Multi-Center Retrospective Cohort StudyAhmad Albshesh, Joshua Taylor, Edoardo V Savarino, et al.
Journal of Crohn'S & Colitis|June 15, 2024
ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical TreatmentMichel Adamina, Silvia Minozzi, Janindra Warusavitarne, et al.
The Lancet. Gastroenterology & Hepatology|February 17, 2020
Health-care costs of inflammatory bowel disease in a pan-European, community-based, inception cohort during 5 years of follow-up: a population-based studyJohan Burisch, Hillel Vardi, Doron Schwartz, et al.
Inflammatory Bowel Diseases|December 2, 2014
Costs and resource utilization for diagnosis and treatment during the initial year in a European inflammatory bowel disease inception cohort: an ECCO-EpiCom StudyJohan Burisch, Hillel Vardi, Natalia Pedersen, et al.
Journal of Gastroenterology and Hepatology|December 19, 2018
Disease course of inflammatory bowel disease unclassified in a European population-based inception cohort: An Epi-IBD studyJohan Burisch, Stefania Chetcuti Zammit, Pierre Ellul, et al.
Gut|January 25, 2018
Natural disease course of Crohn's disease during the first 5 years after diagnosis in a European population-based inception cohort: an Epi-IBD studyJohan Burisch, Gediminas Kiudelis, Limas Kupcinskas, et al.
United European Gastroenterology Journal|July 28, 2020
The use of 5-aminosalicylate for patients with Crohn's disease in a prospective European inception cohort with 5 years follow-up - an Epi-IBD studyJohan Burisch, Daniel Bergemalm, Jonas Halfvarson, et al.
Journal of Crohn'S & Colitis|October 6, 2018
Natural Disease Course of Ulcerative Colitis During the First Five Years of Follow-up in a European Population-based Inception Cohort-An Epi-IBD StudyJohan Burisch, Konstantinos H Katsanos, Dimitrios K Christodoulou, et al.
Journal of Crohn'S & Colitis|June 3, 2017
Occurrence of Anaemia in the First Year of Inflammatory Bowel Disease in a European Population-based Inception Cohort-An ECCO-EpiCom StudyJohan Burisch, Zsuzsanna Vegh, Konstantinnos H Katsanos, et al.
Pageof 28

Showing results (261-270 of 272) with videos related to

Sort By:
Pageof 28
Journal of Crohn'S & Colitis|November 20, 2019
ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical TreatmentMichel Adamina, Stefanos Bonovas, Tim Raine, et al.
Journal of Clinical Medicine|July 2, 2021
Effectiveness of Third-Class Biologic Treatment in Crohn's Disease: A Multi-Center Retrospective Cohort StudyAhmad Albshesh, Joshua Taylor, Edoardo V Savarino, et al.
Journal of Crohn'S & Colitis|June 15, 2024
ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical TreatmentMichel Adamina, Silvia Minozzi, Janindra Warusavitarne, et al.
The Lancet. Gastroenterology & Hepatology|February 17, 2020
Health-care costs of inflammatory bowel disease in a pan-European, community-based, inception cohort during 5 years of follow-up: a population-based studyJohan Burisch, Hillel Vardi, Doron Schwartz, et al.
Inflammatory Bowel Diseases|December 2, 2014
Costs and resource utilization for diagnosis and treatment during the initial year in a European inflammatory bowel disease inception cohort: an ECCO-EpiCom StudyJohan Burisch, Hillel Vardi, Natalia Pedersen, et al.
Journal of Gastroenterology and Hepatology|December 19, 2018
Disease course of inflammatory bowel disease unclassified in a European population-based inception cohort: An Epi-IBD studyJohan Burisch, Stefania Chetcuti Zammit, Pierre Ellul, et al.
Gut|January 25, 2018
Natural disease course of Crohn's disease during the first 5 years after diagnosis in a European population-based inception cohort: an Epi-IBD studyJohan Burisch, Gediminas Kiudelis, Limas Kupcinskas, et al.
United European Gastroenterology Journal|July 28, 2020
The use of 5-aminosalicylate for patients with Crohn's disease in a prospective European inception cohort with 5 years follow-up - an Epi-IBD studyJohan Burisch, Daniel Bergemalm, Jonas Halfvarson, et al.
Journal of Crohn'S & Colitis|October 6, 2018
Natural Disease Course of Ulcerative Colitis During the First Five Years of Follow-up in a European Population-based Inception Cohort-An Epi-IBD StudyJohan Burisch, Konstantinos H Katsanos, Dimitrios K Christodoulou, et al.
Journal of Crohn'S & Colitis|June 3, 2017
Occurrence of Anaemia in the First Year of Inflammatory Bowel Disease in a European Population-based Inception Cohort-An ECCO-EpiCom StudyJohan Burisch, Zsuzsanna Vegh, Konstantinnos H Katsanos, et al.
Pageof 28